tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Peter Verdult, 15 are a BUY (60%), 8 are a HOLD (32%), 2 are a SELL (8%).
Analyst Peter Verdult, currently employed at CITI, carries an average stock price target met ratio of 20.83% that have a potential upside of 6.64% achieved within 120 days. Previously, Peter Verdult worked at GOLDMAN SACHS.
Peter Verdult’s has documented 49 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 12-Nov-2025.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 1/20/2021. The price target of $41.57 was fulfilled within 184 days with a profit of $8.53 (25.82%) receiving and performance score of 1.4.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 16-Oct-2020
$32
$-1.11 (-3.35%)
$28
2 months 5 days ago
(07-Nov-2025)
13/16 (81.25%)
$0.47 (1.49%)
39
Sell
Since 14-Feb-2025
$22
$-11.11 (-33.55%)
$31
10 months 29 days ago
(14-Feb-2025)
3/6 (50%)
$-3.44 (-13.52%)
376
Sell
Since 23-Jan-2025
$82.77
11 months 20 days ago
(23-Jan-2025)
2/7 (28.57%)
$-1.59 (-1.88%)
32
Sell
Since 23-Jan-2023
$49
11 months 20 days ago
(23-Jan-2025)
2/5 (40%)
$2.78 (6.01%)
49
Sell
Since 01-Apr-2024
$31
$-2.11 (-6.37%)
$44
1 years 9 months 11 days ago
(01-Apr-2024)
6/9 (66.67%)
$-1.48 (-4.56%)
14
Which stock is Peter Verdult is most bullish on?
What Year was the first public recommendation made by Peter Verdult?
